Peroxisome proliferator-activated receptor alpha (PPARalpha) potentiates, whereas PPARgamma attenuates, glucose-stimulated insulin secretion in pancreatic beta-cells - PubMed (original) (raw)
. 2005 Aug;146(8):3266-76.
doi: 10.1210/en.2004-1430. Epub 2005 May 5.
Affiliations
- PMID: 15878969
- DOI: 10.1210/en.2004-1430
Peroxisome proliferator-activated receptor alpha (PPARalpha) potentiates, whereas PPARgamma attenuates, glucose-stimulated insulin secretion in pancreatic beta-cells
Kim Ravnskjaer et al. Endocrinology. 2005 Aug.
Abstract
Fatty acids (FAs) are known to be important regulators of insulin secretion from pancreatic beta-cells. FA-coenzyme A esters have been shown to directly stimulate the secretion process, whereas long-term exposure of beta-cells to FAs compromises glucose-stimulated insulin secretion (GSIS) by mechanisms unknown to date. It has been speculated that some of these long-term effects are mediated by members of the peroxisome proliferator-activated receptor (PPAR) family via an induction of uncoupling protein-2 (UCP2). In this study we show that adenoviral coexpression of PPARalpha and retinoid X receptor alpha (RXRalpha) in INS-1E beta-cells synergistically and in a dose- and ligand-dependent manner increases the expression of known PPARalpha target genes and enhances FA uptake and beta-oxidation. In contrast, ectopic expression of PPARgamma/RXRalpha increases FA uptake and deposition as triacylglycerides. Although the expression of PPARalpha/RXRalpha leads to the induction of UCP2 mRNA and protein, this is not accompanied by reduced hyperpolarization of the mitochondrial membrane, indicating that under these conditions, increased UCP2 expression is insufficient for dissipation of the mitochondrial proton gradient. Importantly, whereas expression of PPARgamma/RXRalpha attenuates GSIS, the expression of PPARalpha/RXRalpha potentiates GSIS in rat islets and INS-1E cells without affecting the mitochondrial membrane potential. These results show a strong subtype specificity of the two PPAR subtypes alpha and gamma on lipid partitioning and insulin secretion when systematically compared in a beta-cell context.
Comment in
- Peroxisome proliferator-activated receptors and insulin secretion.
Terauchi Y, Kadowaki T. Terauchi Y, et al. Endocrinology. 2005 Aug;146(8):3263-5. doi: 10.1210/en.2005-0526. Endocrinology. 2005. PMID: 16009973 No abstract available.
Similar articles
- Peroxisome proliferator-activated receptor-alpha regulates the expression of pancreatic/duodenal homeobox-1 in rat insulinoma (INS-1) cells and ameliorates glucose-induced insulin secretion impaired by palmitate.
Sun Y, Zhang L, Gu HF, Han W, Ren M, Wang F, Gong B, Wang L, Guo H, Xin W, Zhao J, Gao L. Sun Y, et al. Endocrinology. 2008 Feb;149(2):662-71. doi: 10.1210/en.2007-1275. Epub 2007 Nov 8. Endocrinology. 2008. PMID: 17991720 - Transcriptional co-activator peroxisome proliferator-activated receptor (PPAR)gamma co-activator-1beta is involved in the regulation of glucose-stimulated insulin secretion in INS-1E cells.
Oberkofler H, Hafner M, Felder T, Krempler F, Patsch W. Oberkofler H, et al. J Mol Med (Berl). 2009 Mar;87(3):299-306. doi: 10.1007/s00109-008-0425-0. Epub 2008 Dec 11. J Mol Med (Berl). 2009. PMID: 19082571 - Overexpression of short heterodimer partner recovers impaired glucose-stimulated insulin secretion of pancreatic beta-cells overexpressing UCP2.
Suh YH, Kim SY, Lee HY, Jang BC, Bae JH, Sohn JN, Bae JH, Suh SI, Park JW, Lee KU, Song DK. Suh YH, et al. J Endocrinol. 2004 Oct;183(1):133-44. doi: 10.1677/joe.1.05675. J Endocrinol. 2004. PMID: 15525581 - Endogenous regulation of insulin secretion by UCP2.
Chan CB. Chan CB. Clin Lab. 2002;48(11-12):599-604. Clin Lab. 2002. PMID: 12465744 Review. - Mitochondrial uncoupling protein 2 in pancreatic β-cells.
Brand MD, Parker N, Affourtit C, Mookerjee SA, Azzu V. Brand MD, et al. Diabetes Obes Metab. 2010 Oct;12 Suppl 2:134-40. doi: 10.1111/j.1463-1326.2010.01264.x. Diabetes Obes Metab. 2010. PMID: 21029310 Review.
Cited by
- Retinoic acid receptor signaling is required to maintain glucose-stimulated insulin secretion and β-cell mass.
Brun PJ, Grijalva A, Rausch R, Watson E, Yuen JJ, Das BC, Shudo K, Kagechika H, Leibel RL, Blaner WS. Brun PJ, et al. FASEB J. 2015 Feb;29(2):671-83. doi: 10.1096/fj.14-256743. Epub 2014 Nov 11. FASEB J. 2015. PMID: 25389133 Free PMC article. - Evaluation of the INS-1 832/13 cell line as a beta-cell based screening system to assess pollutant effects on beta-cell function.
Hectors TL, Vanparys C, Pereira-Fernandes A, Martens GA, Blust R. Hectors TL, et al. PLoS One. 2013;8(3):e60030. doi: 10.1371/journal.pone.0060030. Epub 2013 Mar 21. PLoS One. 2013. PMID: 23555872 Free PMC article. - PPARs at the crossroads of T cell differentiation and type 1 diabetes.
Riaz F, Wei P, Pan F. Riaz F, et al. Front Immunol. 2023 Oct 20;14:1292238. doi: 10.3389/fimmu.2023.1292238. eCollection 2023. Front Immunol. 2023. PMID: 37928539 Free PMC article. Review. - JunD Regulates Pancreatic β-Cells Function by Altering Lipid Accumulation.
Wang K, Cui Y, Lin P, Yao Z, Sun Y. Wang K, et al. Front Endocrinol (Lausanne). 2021 Jul 16;12:689845. doi: 10.3389/fendo.2021.689845. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34335468 Free PMC article. - β-Cell Dysfunction, Hepatic Lipid Metabolism, and Cardiovascular Health in Type 2 Diabetes: New Directions of Research and Novel Therapeutic Strategies.
Al-Mrabeh A. Al-Mrabeh A. Biomedicines. 2021 Feb 23;9(2):226. doi: 10.3390/biomedicines9020226. Biomedicines. 2021. PMID: 33672162 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous